Sign in

ARS Pharmaceuticals, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.08 0.09 0.00 0.00 0.01 0.02
Cost of revenue 0.02 0.02 0.00 0.02 0.00 0.01 0.00 0.00
Gross profit 0.06 0.07 0.00 -0.02 0.01 0.00 0.00 0.00
Total operating expenses + 0.24 0.07 0.07 0.02 0.02 0.00 0.02 0.02
Operating income -0.18 0.00 -0.07 -0.04 -0.02 0.00 -0.02 -0.02
Non-operating income (net) 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Income before tax -0.17 0.01 -0.05 -0.03 -0.02 0.00 -0.02 -0.02
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.17 0.01 -0.05 -0.03 -0.02 0.00 -0.02 -0.02
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Jun-20 Mar-20 Dec-19
Total revenue 0.02 0.03 0.03 0.02 0.01 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Gross profit 0.02 0.02 0.02 0.01 0.00 0.08 0.00 0.00 -0.01 0.00 0.00 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.08 0.07 0.08 0.06 0.04 0.04 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01
Operating income -0.06 -0.04 -0.05 -0.05 -0.04 0.05 -0.02 -0.02 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 0.00 -0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.06 -0.04 -0.05 -0.04 -0.03 0.05 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.06 -0.04 -0.05 -0.04 -0.03 0.05 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.01 -0.01 -0.01
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.24 0.31 0.23 0.27 0.06 0.02 0.01 0.02
Accounts receivable, net 0.03 0.01 0.00 0.00 0.00 0.00
Inventories 0.01 0.01 0.00 0.00 -0.01 0.00
Other current assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.28 0.33 0.23 0.28 0.06 0.03 0.01 0.02
Total non-current assets + 0.04 0.02 0.00 0.00 0.00 0.00 0.01 0.01
Total assets 0.33 0.35 0.23 0.28 0.06 0.03 0.02 0.03
Total current liabilities + 0.04 0.02 0.00 0.01 0.01 0.01 0.02 0.01
Total non-current liabilities + 0.17 0.07 0.00 0.00 0.08 0.03 0.00 0.00
Total liabilities 0.21 0.09 0.00 0.01 0.09 0.04 0.02 0.01
Total stockholders' equity + 0.11 0.26 0.23 0.27 -0.03 -0.01 -0.01 0.02
Common shares outstanding 99 102 95 40 29 35 33 33
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Jun-20 Mar-20 Dec-19
Total cash and short-term investments + 0.20 0.24 0.29 0.24 0.28 0.31 0.20 0.22 0.22 0.23 0.24 0.25 0.26 0.27 0.10 0.08 0.25 0.06 0.30 0.36 0.37 0.39 0.00 0.00 0.01
Accounts receivable, net 0.03 0.03 0.04 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.25 0.28 0.34 0.28 0.30 0.33 0.21 0.22 0.23 0.23 0.24 0.26 0.27 0.28 0.04 0.05 0.26 0.06 0.31 0.36 0.38 0.39 0.01
Total non-current assets + 0.04 0.04 0.03 0.03 0.02 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.05 0.00 0.00 0.00 0.01
Total assets 0.29 0.33 0.37 0.31 0.33 0.35 0.22 0.22 0.23 0.23 0.25 0.26 0.27 0.28 0.04 0.05 0.31 0.06 0.35 0.37 0.38 0.39 0.02
Total current liabilities + 0.05 0.04 0.05 0.05 0.03 0.02 0.02 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.02
Total non-current liabilities + 0.18 0.17 0.17 0.08 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.08 0.00 0.08 0.01 0.00 0.00 0.00 0.00
Total liabilities 0.23 0.21 0.23 0.12 0.10 0.09 0.02 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.09 0.02 0.09 0.02 0.02 0.01 0.01 0.02
Total stockholders' equity + 0.06 0.11 0.15 0.19 0.23 0.26 0.20 0.22 0.22 0.23 0.24 0.25 0.26 0.27 0.03 -0.04 0.29 -0.03 0.33 0.35 0.37 0.38 -0.01
Common shares outstanding 99 99 99 98 98 98 97 97 96 96 96 95 94 94 94 94 94 35 35 35 35 35 35 33 33
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.17 0.01 -0.06 -0.04 -0.02 0.01 -0.02 -0.02
Cash flow from investing + 0.06 -0.11 -0.09 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.10 0.07 0.01 0.19 0.05 0.01 0.01 0.02
Change in cash -0.01 -0.02 -0.14 0.15 0.04 0.01 -0.01 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Jun-20 Mar-20
Operating cash flow + -0.04 -0.04 -0.05 -0.04 -0.04 0.04 -0.01 -0.01 -0.01 -0.02 -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01
Cash flow from investing + 0.03 0.02 -0.04 0.05 0.03 -0.10 0.02 -0.01 -0.01 0.03 -0.05 0.04 -0.11 0.00 0.00 0.00 0.00 -0.03 -0.04 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.10 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02
Change in cash -0.02 -0.02 0.01 0.01 -0.01 0.01 0.00 -0.02 -0.01 0.01 -0.06 0.03 -0.12 0.17 -0.01 -0.01 -0.01 -0.05 -0.06 -0.01 -0.01 0.01 0.01
5 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Operating Cashflow

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Other Non Operating Income

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Income Tax Expense

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Net Income

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Ebitda

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Ebit

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Net Income From Continuing Operations

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Income Before Tax

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Depreciation And Amortization

1Y 2Y 5Y Max
9 days ago

ARS Pharmaceuticals, Inc. (SPRY) - Interest Expense

1Y 2Y 5Y Max
9 days ago